i'SUPPLY Concludes Its Pre-series A Round

Egypt-based B2B medtech i‘SUPPLY has closed its pre-series A round, bringing the total raised funds to $2.5 million since its inception.^[1]  

This funding was backed by Egypt Ventures, OneStop Capital, Axian Investment CVC, and Disruptech Ventures, among other venture capital firms.

Last year, DisrupTech Fund—a venture capital firm with a focus on financial technology—announced its strategic investment in Cairo-based financial services company Banknbox.

i'SUPPLY provided tech-enabled platform support to pharmacies and small to medium-sized distribution organizations. Since its founding, i'SUPPLY has processed over a million purchase orders annually and is anticipated to have an annual transaction volume of EGP 1 billion ($21.032 million).

The company’s integrated network serves over 10,000 pharmacies and collaborates with more than 200 distribution businesses, delivering a catalog of over 10,000 pharmaceutical products. Remarkably, i'SUPPLY recorded a five-fold rise in revenue and transactions from January to May 2024 when compared to the same time in 2023.

Ibrahim Emam, Ramzy Mohamed, and Moustafa Zaki founded i'SUPPLY in 2022 to digitize the pharmaceutical industry. They aimed to offer a one-stop-shop for anticipating and resolving supply chain issues promptly.

The new funding round will support i'SUPPLY's growth objectives. It will improve the company's capacity to finance small and medium-sized pharmacies. It will expand fintech solutions and advance technology services.

i'SUPPLY bagged $1.5 million in its pre-seed round. Disruptech Ventures headed this round in 2022.

In 2024, the pharmaceuticals market in Egypt is expected to generate $1.449 million in revenue, according to data from Statista.^[2]  

With a predicted market volume of $240 million in the same year, Oncology Drugs holds the greatest market share among the various markets.

The market is anticipated to reach a value of $1.948 million by 2028.